During the company's third quarter earnings call, CEO Mark Casper highlighted a number of recent clinical and diagnostic product launches and initiatives.
Samsung has been awarded US Patent No. 8,618,253, "Modified RNAse H and detection of nucleic acid amplification."
Win Den Chung and Jason Opdyke are named as inventors.
Bio-Rad Laboratories has been awarded US Patent No. 8,560,247, "Multi-stage, regression-based PCR analysis system."
Jeffrey Lerner is named as the inventor.
In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.
